News
TMCI
4.465
-28.33%
-1.765
Treace Medical’s Earnings Call: Growth Amid Challenges
TipRanks · 1d ago
Is Treace Medical Concepts (NASDAQ:TMCI) Using Too Much Debt?
Simply Wall St · 1d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 2d ago
Nasdaq Tumbles Over 100 Points; US Consumer Sentiment Falls In November
Benzinga · 2d ago
Treace Medical Concepts Slides After Cut to Full-Year Revenue Outlook
Dow Jones · 2d ago
Treace Medical Concepts Is Maintained at Neutral by UBS
Dow Jones · 2d ago
Treace Medical Concepts Price Target Cut to $5.85/Share From $6.50 by UBS
Dow Jones · 2d ago
UBS Maintains Neutral on Treace Medical Concepts, Lowers Price Target to $5.85
Benzinga · 2d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 2d ago
Treace Medical price target lowered to $5 from $6 at Stifel
TipRanks · 2d ago
Treace Medical plunges despite Q3 beat; BTIG downgrades on guidance cut
Seeking Alpha · 2d ago
Treace Medical revises 2025 revenue guidance to $211M-$213M as demand shifts and new products expand market reach
Seeking Alpha · 2d ago
Treace Medical (TMCI) Q3 2025 Earnings Transcript
NASDAQ · 2d ago
Treace Medical Concepts (TMCI) Gets a Hold from Stifel Nicolaus
TipRanks · 2d ago
TREACE MEDICAL CONCEPTS INC <TMCI.O>: UBS CUTS TARGET PRICE TO $5.85 FROM $6.5
Reuters · 2d ago
Treace Medical price target lowered to $7.50 from $12 at Lake Street
TipRanks · 2d ago
Treace Medical Concepts to Participate in UBS Global Healthcare Conference
Reuters · 2d ago
Treace Medical price target lowered to $5.85 from $6.50 at UBS
TipRanks · 2d ago
Treace Medical Concepts Cut to Underweight From Neutral by JP Morgan
Dow Jones · 2d ago
Treace Medical Concepts Price Target Cut to $5.00/Share From $8.00 by JP Morgan
Dow Jones · 2d ago
More
Webull provides a variety of real-time TMCI stock news. You can receive the latest news about Treace Medical Concepts, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About TMCI
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.